BENZENO SHARON Insider Trades

Insider Trading History

Track insider trading activity for BENZENO SHARON. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Ofc Imm Med
Holding Value $5.07M 221,278 shares
Last Trade
Jun 29, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.27M 154,768 shares
$21.14
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Ofc Imm Med
Holding Value $2.6M 113,457 shares
Last Trade
Jun 29, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.21M 103,295 shares
$21.40
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Ofc Imm Med
Holding Value $8.61M 376,046 shares
Last Trade
Jun 29, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.21M 103,295 shares
$21.40
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Ofc Imm Med
Holding Value $6.5M 283,785 shares
Last Trade
Jun 26, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$231k 11,034 shares
$20.96
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Ofc Imm Med
Holding Value $42.1k 1,837 shares
Last Trade
Jun 26, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$231k 11,034 shares
$20.96
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Ofc Imm Med
Holding Value $6.25M 272,751 shares
Last Trade
Jun 26, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$232k 11,034 shares
$21.00
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Ofc Imm Med
Holding Value $6.25M 272,751 shares
Last Trade
Mar 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$831k 63,103 shares
$13.17
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Ofc Imm Med
Holding Value $7.69M 335,854 shares
Last Trade
Mar 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$642k 39,063 shares
$16.44
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Ofc Imm Med
Holding Value $6.89M 301,081 shares
Last Trade
Dec 04, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$74.9k 4,290 shares
$17.46
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Ofc Imm Med
Holding Value $2.57M 112,247 shares
Last Trade
Dec 04, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$72.6k 4,157 shares
$17.46
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Ofc Imm Med
Holding Value $1.43M 62,360 shares
Last Trade
Dec 04, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$72.6k 4,157 shares
$17.46
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Ofc Imm Med
Holding Value $295k 12,871 shares
Last Trade
Dec 04, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$74.9k 4,290 shares
$17.46
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Ofc Imm Med
Holding Value $7.09M 309,395 shares
Last Trade
Dec 04, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$72.6k 4,157 shares
$17.46
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Ofc Imm Med
Holding Value $6.99M 305,238 shares
Last Trade
Dec 04, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$72.6k 4,157 shares
$17.46
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Ofc Imm Med
Holding Value $6.8M 296,791 shares
Last Trade
Dec 04, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$212k 12,604 shares
$16.85
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Ofc Imm Med
Holding Value $6.82M 297,625 shares
Last Trade
Nov 21, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$15.5k 834 shares
$18.61
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Ofc Imm Med
Holding Value $13.9M 605,268 shares
Last Trade
Nov 21, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.55M 83,145 shares
$18.61
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Ofc Imm Med
Holding Value $12M 522,123 shares
Last Trade
Nov 21, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.23M 119,809 shares
$18.61
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Ofc Imm Med
Holding Value $9.21M 402,314 shares
Last Trade
Nov 21, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$640k 34,375 shares
$18.61
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Ofc Imm Med
Holding Value $8.43M 367,939 shares
Last Trade
Nov 21, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$921k 49,480 shares
$18.61
$22.90

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up